跳至主要内容
临床试验/NCT00465530
NCT00465530已完成不适用

Safety and Efficacy of Once Daily Intranasal Gentamycin Irrigation Versus Saline in the Treatment of Pediatric Chronic Sinusitis

Julie Wei, MD2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2007年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Change in Computed Tomography (CT) Score After Treatment

研究概览

简要总结

Healthy children may develop symptoms of chronic sinusitis such as chronic cough, chronic runny nose, nasal congestion, even headaches. Such symptoms may persist long after the child gets over other symptoms of a cold and commonly result in the prescription of oral antibiotics. The purpose of this study is to evaluate whether using saline alone or saline plus an antibiotic (gentamycin) to irrigate the nose directly once a day for 6 weeks is effective and safe for the treatment of the above named symptoms. Computerized axial tomography (CAT) scans and quality of life surveys will be used to compare the health of the sinuses before and after treatment, and scored to determine which of the two treatments, saline alone or saline with gentamycin, is more effective in the treatment of this condition. The study hypothesis is that intranasal saline irrigation will work as well as saline plus gentamycin, and that majority of the patients will experience significant improvement after a 6 week treatment period.

详细描述

In the pediatric population, rhinosinusitis is a common concern resulting frequently in the frequent and unsuccessful prescription of systemic oral antibiotic therapy. Children typically experience an estimated 6-8 upper respiratory illnesses per year, usually viral, and only 13% are estimated to result in true sinusitis. True and chronic sinusitis, if not adequately treated, may result in long term symptoms including nasal airway obstruction, nasal congestion, persistent mucopurulent rhinorrhea, daytime and nocturnal cough, headaches, daytime fatigue, and even exacerbation or poor control of underlying asthma. A child's quality of life can be severely impacted as is their caretaker's due to days of missed school, frequency of doctor visits and courses of oral antibiotic therapy prescribed for the above mentioned symptoms, which ultimately result in the development of resistant organisms in addition to potential negative side effects associated with systemic oral antibiotic use.

Intranasal saline irrigation is underutilized in the pediatric population, most likely due to the presumption that children will not cooperate nor tolerate the act of irrigation. Saline irrigation of the nose is an inexpensive and generally well tolerated treatment with very little side effects or risks. Rigorous data regarding the efficacy of saline irrigation has become more available in this past decade, with most studies demonstrating a clear improvement in patient quality of life as measured by various study instruments or outcome surveys.

In our protocol, patients will be randomized to receive either saline alone or saline plus gentamycin in the solution form for nasal irrigation once daily for a six week treatment period. Weekly phone calls will be made to check for possible adverse events while patients are on treatment, and at the end of the treatment period another CAT scan will be performed to assess the status of the sinuses. Overall improvement will be determined based on the sinus status on the second CAT scan as well as the quality of life survey filled out by parents.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
4 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Healthy children age 4-17
  • History of "Recurrent" or "Chronic Sinusitis"
  • Definition: History must include > 3 months of any or a combination of the following symptoms:
  • Nasal congestion/nasal airway obstruction
  • Rhinorrhea/Nasal discharge
  • Persistent cough (daytime)
  • Postnasal drip
  • Facial pain
  • Foul breath
  • Intermittent fever
  • Caregiver (proxy responsible) able to read and understand English
  • Has had at least 3 courses or a total of 21 days of oral antibiotic therapy for above symptoms in the previous 3 months
  • Child has a CT scan of the coronal sinus without contrast within two months prior to visit date, which demonstrates and opacification of a single or multiple, ipsilateral or bilateral sinuses.

排除标准

  • Inability of caregiver to read and understand English
  • Mental retardation, cognitive impairment, or developmental delay
  • History of cystic fibrosis
  • History of immotile cilia syndrome
  • History of immune suppression/immune compromise
  • CT scan within past 4 weeks available for review at time of clinic visit which is entirely negative for evidence of sinus disease plus complete absence of any of the above symptoms
  • History of endoscopic sinus surgery
  • History of patient's inability to tolerate attempted nasal irrigation in the past 6 months
  • History of recent use of gentamycin intranasal irrigation or saline irrigation within the past 3 months
  • History of presence of nasal polyposis
  • History of allergic reaction of any kind to intravenous gentamycin or aminoglycosides in past medical history (for treatment of any infections)

研究组 & 干预措施

2

Experimental

Saline plus Gentamycin

干预措施: Saline (Drug)

2

Experimental

Saline plus Gentamycin

干预措施: Gentamycin (Drug)

1

Placebo Comparator

Saline

干预措施: Saline (Drug)

结局指标

主要结局

Change in Computed Tomography (CT) Score After Treatment

时间窗: Change from Baseline to 6 Weeks

Change in CT score reflects the Lund-Mackay staging system. Each sinus is scored separately and scores are determined for the right and the left side. The lowest score of 0 represents no opacification in the sinus. A score of 1 represents a partial opacification. A score of 2 represents complete opacification.

Change in Overall Quality of Life

时间窗: 3 Weeks to Follow-Up (7 Weeks)

Measured by Quality of Life Survey (SN-5). Scores ranged from 0 - 7. The higher the numerical score, the worse the problem.

次要结局

  • Change in Overall Quality of Life(Baseline to 3 Weeks)

研究者

发起方
Julie Wei, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Julie Wei, MD

Associate Professor

University of Kansas Medical Center

研究点 (2)

Loading locations...

相似试验